Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Syros Pharmaceuticals (NQ: SYRS )

2.990 +0.190 (+6.79%)
Streaming Delayed Price Updated: 3:05 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Syros Pharmaceuticals

< Previous 1 2 3 Next >
Syros Presents New Data from Phase 1 Trial of SY-5609 and Details Three-Pronged Combination Strategy to Advance SY-5609 in Solid Tumors and Blood Cancer
From Syros Pharmaceuticals
Via Business Wire
Syros to Present New Data from Phase 1 Clinical Trial of SY-5609 in Oral Presentation at ESMO Congress 2021
From Syros Pharmaceuticals
Via Business Wire
Syros Announces Appointment of Deborah Dunsire, M.D., to Its Board of Directors
From Syros Pharmaceuticals
Via Business Wire
Syros Announces First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Newly Diagnosed Unfit AML
From Syros Pharmaceuticals
Via Business Wire
Syros to Present at Upcoming Investor Conferences in September
From Syros Pharmaceuticals
Via Business Wire
Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
From Syros Pharmaceuticals
Via Business Wire
Syros Announces Agreement with Roche to Evaluate SY-5609 as Part of a Novel Combination for Treatment of Colorectal Cancer
From Syros Pharmaceuticals
Via Business Wire
Syros to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
From Syros Pharmaceuticals
Via Business Wire
Syros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference
From Syros Pharmaceuticals
Via Business Wire
Syros to Host Key Opinion Leader Webcast Series on Targeted Hematology Portfolio
From Syros Pharmaceuticals
Via Business Wire
Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
From Syros Pharmaceuticals
Via Business Wire
Syros to Report First Quarter 2021 Financial Results on Thursday May 6, 2021
From Syros Pharmaceuticals
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.